Award

PHDSTU-Hist\100094

Funder: Cancer Research UK

Funded outputs count: 13

Funder award ID: PHDSTU-Hist\100094

OpenAlex ID: G190134582

A survey on clinical natural language processing in the United Kingdom from 2007 to 2022

2022 · Honghan Wu, Minhong Wang, et al. · npj Digital Medicine · 105

Impact of tumour characteristics and cancer treatment on cerebrovascular mortality after glioma diagnosis: Evidence from a population-based cancer registry

2022 · Kai Jin, Paul M. Brennan, et al. · Frontiers in Oncology · 4

Association of extent of resection and functional outcomes in diffuse low-grade glioma: systematic review & meta-analysis

2022 · Mustafa Elsheikh, Elsie Bridgman, et al. · Journal of Neuro-Oncology · 18

Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland

2022 · James J M Loan, Steven Tominey, et al. · Stroke and Vascular Neurology · 5

Imaging timing after glioblastoma surgery (INTERVAL-GB): protocol for a UK and Ireland, multicentre retrospective cohort study

2022 · Conor S Gillespie, Emily R Bligh, et al. · BMJ Open · 9

Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review

2022 · Georgios Solomou, Aref-Ali Gharooni, et al. · BMJ Open · 6

Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review

2022 · Beth Fitt, Grace Loy, et al. · PLoS ONE · 5

Standardizing reporting of brain and central nervous system tumors in the United Kingdom

2022 · Michael T C Poon, Paul M Brennan, et al. · Neuro-Oncology

Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies

2021 · Michael TC Poon, Morgan Bruce, et al. · BMC Cancer · 80

MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: A single-center experience

2021 · Olimpia E Curran, Michael T C Poon, et al. · Neuro-Oncology Advances · 11

Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study

2021 · Michael T C Poon, Shivank Keni, et al. · Neuro-Oncology Advances · 30

Might changes in diagnostic practice explain increasing incidence of brain and central nervous system tumors? A population-based study in Wales (United Kingdom) and the United States

2020 · Michael Tin Chung Poon, Paul M Brennan, et al. · Neuro-Oncology · 13

Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis

2020 · Michael T. C. Poon, Cathie L. M. Sudlow, et al. · Scientific Reports · 316